2022-08-12T16:25:13-04:00 2021-06-30 264150644 EARLY GROWTH FINANCIAL SERVICES 2345 YALE ST 1ST FL PALO ALTO CA 94306 990 2020-07-01 851085804 PHARE BIO INC PHAR 6174265900 303 CONGRESS ST 2ND FL BOSTON MA 02210 AKHILA KOSARAJU CEO 6502706137 2022-05-15 AKHILA KOSARAJU XXX-XX-XXXX ANJUM TUNULI P00023162 4152343437 2022-08-12 2020 2022-09-23 18:48:47Z X AKHILA KOSARAJU 303 CONGRESS ST 2ND FL BOSTON MA 02210 1057242 false X PHAREBIO.ORG X NON PROFIT 2020 SEE SCHEDULE O 5 4 1 0 1057242 0 0 0 1057242 0 0 200373 0 0 253059 453432 603810 632271 28461 603810 X PHARE BIO'S MISSION IS TO DEVELOP CRITICALLY NEEDED ANTIBIOTICS TO ADDRESS A LOOMING CRISIS IN ANTIBIOTIC RESISTANCE. USING NOVEL AI AND DEEP LEARNING APPROACHES, PHARE BIO AIMS TO RAPIDLY DISCOVER AND DEVELOP NEW CLASSES OF ANTIBIOTICS AGAINST THE DEADLIEST PATHOGENS, AND ENSURE THAT THESE THERAPIES REACH THE PATIENTS IN GREATEST NEED. false false IN ITS FIRST PARTIAL YEAR OF OPERATIONS, THE ORGANIZATION PRIORITIZED RECRUITING AND INITIATING ANTIBIOTIC RESEARCH AND DEVELOPMENT PROGRAMS. 61562 IN ITS FIRST PARTIAL YEAR OF OPERATIONS, THE ORGANIZATION PRIORITIZED RECRUITING AND INITIATING ANTIBIOTIC RESEARCH AND DEVELOPMENT PROGRAMS. 61562 61562 true true false false false false false false false false false false false false true false false false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false true 0 0 false 1 true false false false false false false false false X 5 4 false false false false false false false true true false false false true true true true true true false false MA NY X AKHILA KOSARAJU 6174265900 303 CONGRESS ST 2ND FL BOSTON MA 02210 AKHILA KOSARAJU CEO 40.00 X 175154 0 0 175154 1 false true false THE CERVINO GROUP 5200 HARPER ROAD SOLON OH 44139 RECRUITING 155000 1 1057242 1057242 1057242 X 175154 21894 153260 13448 1681 11767 11771 1471 10300 4104 4104 23844 7749 16095 14854 14854 183767 28767 155000 20600 20600 444 444 158 158 63 63 4470 4470 411 411 WEBSITE CHARGES 204 204 BANK FEES 140 140 453432 61562 391870 0 619730 12541 0 632271 16969 11492 0 28461 X 603810 0 603810 0 632271 603810 X false false X 1057242 1057242 1057242 1057242 178855 878387 1057242 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 401K PAYABLE 6050 ACCRUED EXPENSES 5152 ACCRUED PAYROLL 290 11492 X X X X X X false false false false false false false false false AKHILA KOSARAJU CEO 175154 175154 FORM 990, PAGE 1, ITEM B WRONG YEAR FORM WAS USED FOR THE 4/29/20 - 6/30/20 PERIOD. FILING THE CORRECT 2020 TAX RETURN FOR THE PERIOD 7/1/20 - 6/30/21. FORM 990 - ORGANIZATION'S MISSION PHARE BIO'S MISSION IS TO DEVELOP CRITICALLY NEEDED ANTIBIOTICS TO ADDRESS A LOOMING CRISIS IN ANTIBIOTIC RESISTANCE. USING NOVEL AI AND DEEP LEARNING APPROACHES, PHARE BIO AIMS TO RAPIDLY DISCOVER AND DEVELOP NEW CLASSES OF ANTIBIOTICS AGAINST THE DEADLIEST PATHOGENS, AND ENSURE THAT THESE THERAPIES REACH THE PATIENTS IN GREATEST NEED. FORM 990, PAGE 2, PART III, LINE 4D IN ITS FIRST PARTIAL YEAR OF OPERATIONS, THE ORGANIZATION PRIORITIZED RECRUITING AND INITIATING ANTIBIOTIC RESEARCH AND DEVELOPMENT PROGRAMS. FORM 990, PAGE 6, PART VI, LINE 11B FORM 990 AND SCHEDULES PREPARED BY ACCOUNTING FIRM AND REVIEWED BY PHARE BIO MANAGEMENT AND THEIR LEGAL COUNSEL. FORM 990, PAGE 6, PART VI, LINE 19 THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS, POLICIES, AND OTHER DOCUMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONTRACT SERVICES 0 155,000 0 RD EXPENSES 20,467 0 0 RD CONSULTANTS 8,300 0 0 TOTAL 28,767 155,000 0